Sandoz Group AG
CH · Healthcare · Stock Sandoz Group AG is a Swiss pharmaceutical company headquartered in Basel, Switzerland, specializing in the development, manufacturing, and commercialization of generic medicines and biosimilars. Spun off from Novartis in October 2023, it is one of the largest standalone generics and biosimilars companies in the world, with a broad product portfolio spanning multiple therapeutic areas. The company is listed on the SIX Swiss Exchange and serves patients in over 100 countries globally.
Dividend Yield
1.26%
TTM · SIX
Last Dividend
0.80
CHF · 2026-04-13
5Y Growth
—
CAGR
Frequency
Annual
Years Paid
3
consecutive
Not Cut
2
consecutive yrs
Grown
2
consecutive yrs
Listings
| Exchange | Ticker | Currency | Yield TTM |
|---|---|---|---|
| SIX primary | SDZ | CHF | 1.26% |
Total Return
Based on 10,000 invested at the start of the period. Price return uses split-adjusted closing prices. Dividends are not reinvested.
Annual Dividends
Annual dividend per share · 3 years of data
Advertisement
Dividend Yield History
Dividend History
| Ex-Date ▼ | Pay-Date ▼ | Amount ▼ | Type ▼ |
|---|---|---|---|
| 13.04.2026 | 15.04.2026 | 0.80 CHF | Ordinary |
| 17.04.2025 | 23.04.2025 | 0.60 CHF | Ordinary |
| 03.05.2024 | 07.05.2024 | 0.45 CHF | Ordinary |